Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    December 2017
  1. MASTERSON L, O'Mahony J, Lechner M
    Expanding the benefits of HPV vaccination to boys and men.
    Lancet. 2017;388:2992.
    PubMed     Text format    


    January 2017
  2. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Text format     Abstract available


    December 2016
  3. HENAO-RESTREPO AM, Camacho A, Longini IM, Watson CH, et al
    Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!).
    Lancet. 2016 Dec 23. pii: S0140-6736(16)32621.
    PubMed     Text format     Abstract available


  4. GROBUSCH MP, Goorhuis A
    Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine.
    Lancet. 2016 Dec 22. pii: S0140-6736(16)32619.
    PubMed     Text format    


  5. GEISBERT TW
    First Ebola virus vaccine to protect human beings?
    Lancet. 2016 Dec 22. pii: S0140-6736(16)32618.
    PubMed     Text format    


  6. ZHU FC, Wurie AH, Hou LH, Liang Q, et al
    Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2016 Dec 22. pii: S0140-6736(16)32617.
    PubMed     Text format     Abstract available


  7. PARIKH SR, Andrews NJ, Beebeejaun K, Campbell H, et al
    Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study.
    Lancet. 2016;388:2775-2782.
    PubMed     Text format     Abstract available


  8. BASTA NE, Christensen H
    4CMenB vaccine effectiveness: reasons for optimism.
    Lancet. 2016;388:2719-2721.
    PubMed     Text format    


    November 2016
  9. ASTURIAS EJ, Bandyopadhyay AS, Clemens R, Orenstein W, et al
    New poliovirus vaccine schedules - Authors' reply.
    Lancet. 2016;388:2478.
    PubMed     Text format    


  10. ZHANG Q, Leppold C, Shao Y, Mura Y, et al
    New poliovirus vaccine schedules.
    Lancet. 2016;388:2477-2478.
    PubMed     Text format    


  11. THE LANCET
    Measles vaccination: global progress, local challenges.
    Lancet. 2016;388:2450.
    PubMed     Text format    


  12. WU JT, Peak CM, Leung GM, Lipsitch M, et al
    Fractional dosing of yellow fever vaccine to extend supply: a modelling study.
    Lancet. 2016 Nov 9. pii: S0140-6736(16)31838.
    PubMed     Text format     Abstract available


    October 2016
  13. HALSTEAD SB, Aguiar M
    Is discussion of dengue vaccination for the 2016 Olympics necessary?: Authors' reply.
    Lancet. 2016;388:1881-1882.
    PubMed     Text format    


  14. SCHWARZ TF
    Is discussion of dengue vaccination for the 2016 Olympics necessary?
    Lancet. 2016;388:1881.
    PubMed     Text format    


  15. ARREDONDO-GARCIA JL, Hadinegoro SR, Guy B, Bouckenooghe A, et al
    Is discussion of dengue vaccination for the 2016 Olympics necessary?
    Lancet. 2016;388:1880-1881.
    PubMed     Text format    


  16. WANG LD, Lam WW, Fielding R
    Parental decision-making with regards to vaccination against human papilloma virus in adolescent girls in Hong Kong, China: a prospective cohort study.
    Lancet. 2016;388 Suppl 1:S78.
    PubMed     Text format     Abstract available


    September 2016
  17. AKANMORI BD, Mukanga DO, Mihigo R, Ward M, et al
    New development of medicines for priority diseases in Africa.
    Lancet. 2016;388:1053-4.
    PubMed     Text format    


  18. ELACHOLA H, Ditekemena J, Zhuo J, Gozzer E, et al
    Yellow fever outbreaks, vaccine shortages and the Hajj and Olympics: call for global vigilance.
    Lancet. 2016 Sep 5. pii: S0140-6736(16)31546.
    PubMed     Text format    


    August 2016
  19. DOIRON PR, Bunker CB
    Expanding the benefits of HPV vaccination to boys and men.
    Lancet. 2016;388:659.
    PubMed     Text format    


    July 2016
  20. THE LANCET
    HPV vaccination: a decade on.
    Lancet. 2016;388:438.
    PubMed     Text format    


  21. MAURICE J
    The Zika virus public health emergency: 6 months on.
    Lancet. 2016;388:449-50.
    PubMed     Text format    


  22. HALSTEAD SB, Aguiar M
    Dengue vaccine and the 2016 Olympics.
    Lancet. 2016;388:237-8.
    PubMed     Text format    


    June 2016
  23. GREEN A
    Yellow fever continues to spread in Angola.
    Lancet. 2016;387:2493.
    PubMed     Text format    


  24. MAYER KH, Shisana O, Beyrer C
    AIDS 2016: from aspiration to implementation.
    Lancet. 2016;387:2484-5.
    PubMed     Text format    


  25. QIU J, Hu H, Zhou S, Liu Q, et al
    Vaccine scandal and crisis in public confidence in China.
    Lancet. 2016;387:2382.
    PubMed     Text format    


    May 2016
  26. CHAN M
    Yellow fever: the resurgence of a forgotten disease.
    Lancet. 2016;387:2165-6.
    PubMed     Text format    


  27. ASTURIAS EJ, Bandyopadhyay AS, Self S, Rivera L, et al
    Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
    Lancet. 2016 May 19. pii: S0140-6736(16)00703.
    PubMed     Text format     Abstract available


  28. PARKER EP, Grassly NC
    Polio vaccination: preparing for a change of routine.
    Lancet. 2016 May 19. pii: S0140-6736(16)30593.
    PubMed     Text format    


  29. O'BRIEN KL, Binka F, Marsh K, Abramson JS, et al
    Mind the gap: jumping from vaccine licensure to routine use.
    Lancet. 2016;387:1887-9.
    PubMed     Text format    


    April 2016
  30. SCHMELER KM, Sturgis EM
    Expanding the benefits of HPV vaccination to boys and men.
    Lancet. 2016;387:1798-9.
    PubMed     Text format    


  31. LOCARNINI S, Chen DS, Shibuya K
    No more excuses: viral hepatitis can be eliminated.
    Lancet. 2016;387:1703-4.
    PubMed     Text format    


  32. MONATH TP, Woodall JP, Gubler DJ, Yuill TM, et al
    Yellow fever vaccine supply: a possible solution.
    Lancet. 2016;387:1599-600.
    PubMed     Text format    


  33. KIENY MP, Longini IM, Henao-Restrepo AM, Watson CH, et al
    Changes in the primary outcome in Ebola vaccine trial--Authors' reply.
    Lancet. 2016;387:1509-10.
    PubMed     Text format    


  34. ZHANG Y, Feng S, Cowling BJ
    Changes in the primary outcome in Ebola vaccine trial.
    Lancet. 2016;387:1509.
    PubMed     Text format    


  35. GESSNER BD, Wraith DC, Finn A
    CNS infection safety signal of RTS,S/AS01 and possible association with rabies vaccine.
    Lancet. 2016;387:1376.
    PubMed     Text format    



  36. Yellow fever: a global reckoning.
    Lancet. 2016;387:1348.
    PubMed     Text format    


    March 2016
  37. MAURICE J
    WHO meeting thrashes out R&D strategy against Zika.
    Lancet. 2016;387:1147.
    PubMed     Text format    


  38. FISH EN, Flanagan KL, Furman D, Klein SL, et al
    Changing oral vaccine to inactivated polio vaccine might increase mortality.
    Lancet. 2016;387:1054-5.
    PubMed     Text format    


    February 2016
  39. WILLISON HJ, Jacobs BC, van Doorn PA
    Guillain-Barre syndrome.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00339.
    PubMed     Text format     Abstract available


  40. LI JX, Zeng M, Mao XH, Zou QM, et al
    Helicobacter pylori vaccination - Authors' reply.
    Lancet. 2016;387:749.
    PubMed     Text format    


  41. LEPPOLD C, Tanimoto T, Ozaki A, Morita T, et al
    Helicobacter pylori vaccination.
    Lancet. 2016;387:748-9.
    PubMed     Text format    


  42. MAURICE J
    WHO reveals its shopping list for weapons against Zika.
    Lancet. 2016;387:733.
    PubMed     Text format    


  43. BAYLISS CD, Morrissey JA, Borrow R
    Men B: lack of coverage or vaccine failure?
    Lancet. 2016;387:531-2.
    PubMed     Text format    


  44. SAMARASEKERA U, Triunfol M
    Concern over Zika virus grips the world.
    Lancet. 2016 Feb 3. pii: S0140-6736(16)00257.
    PubMed     Text format    


    January 2016
  45. LAXMINARAYAN R, Matsoso P, Pant S, Brower C, et al
    Access to effective antimicrobials: a worldwide challenge.
    Lancet. 2016;387:168-75.
    PubMed     Text format     Abstract available


  46. AZMAN AS, Ivers LC, Legros D, Luquero FJ, et al
    Safe water, sanitation, hygiene, and a cholera vaccine.
    Lancet. 2016;387:28.
    PubMed     Text format    


    December 2015
  47. LONGINI IM, Egger M, Dean NE, Edmunds WJ, et al
    Ebola vaccination - Authors' reply.
    Lancet. 2015;386:2480.
    PubMed     Text format    


  48. TSCHUDIN-SUTTER S, Widmer AF, Emmerich P, Schmidt-Chanasit J, et al
    Ebola vaccination.
    Lancet. 2015;386:2478-80.
    PubMed     Text format    


  49. FITZGERALD F, Yeung S, Gibb DM, Baion DE, et al
    Ebola vaccination.
    Lancet. 2015;386:2478.
    PubMed     Text format    


  50. YAQUB F
    2015: review of the year.
    Lancet. 2015;386:2459-60.
    PubMed     Text format    



  51. Time to eliminate rabies.
    Lancet. 2015;386:2446.
    PubMed     Text format    


  52. DEHAL N, Krishan K, Kanchan T, Singh J, et al
    Public-funded immunisation: key to varicella control in India.
    Lancet. 2015;386:2389-90.
    PubMed     Text format    


    November 2015
  53. GARLAND SM, Subasinghe AK, Jayasinghe YL, Wark JD, et al
    HPV vaccination for victims of childhood sexual abuse.
    Lancet. 2015;386:1919-20.
    PubMed     Text format    


  54. PENNY MA, Verity R, Bever CA, Sauboin C, et al
    Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.
    Lancet. 2015 Nov 5. pii: S0140-6736(15)00725.
    PubMed     Text format     Abstract available


  55. GREENWOOD B, Doumbo OK
    Implementation of the malaria candidate vaccine RTS,S/AS01.
    Lancet. 2015 Nov 5. pii: S0140-6736(15)00807.
    PubMed     Text format    


    October 2015
  56. MULLER O, Tozan Y, Becher H
    RTS,S/AS01 malaria vaccine and child mortality.
    Lancet. 2015;386:1736.
    PubMed     Text format    


  57. AABY P, Rodrigues A, Kofoed PE, Benn CS, et al
    RTS,S/AS01 malaria vaccine and child mortality.
    Lancet. 2015;386:1735-6.
    PubMed     Text format    


  58. KHAN TM, Chiau LM
    Polio vaccination in Pakistan: by force or by volition?
    Lancet. 2015;386:1733.
    PubMed     Text format    



  59. What next for the malaria RTS,S vaccine candidate?
    Lancet. 2015;386:1708.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: